Eight months later, while taking dabigatran and mesalamine for stroke prevention and UC maintenance, the patient presented with left sided arm and leg weakness (NIHSS = 4) again outside the 4.5-hour window for treatment with tPA. The gene discussed is PLAT; the disease is stroke disorder.